Clorox financials
$81.60+0.22%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Jun 30 | Q3 '26 Mar 31 | Q2 '26 Dec 31 | Q1 '26 Sep 30 | Q4 '25 Jun 30 | Q3 '25 Mar 31 | Q2 '25 Dec 31 | Q1 '25 Sep 30 | Q4 '24 Jun 30 | Q3 '24 Mar 31 | Q2 '24 Dec 31 | Q1 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.67B | $1.67B | $1.43B | $1.99B | $1.67B | $1.69B | $1.76B | $1.90B | $1.81B | $1.99B | $1.39B |
| Gross profit | $804.0M | $722.0M | $722.0M | $596.0M | $924.0M | $744.0M | $738.0M | $807.0M | $884.0M | $766.0M | $866.0M | $532.0M |
| Gross margin | 41.3% | 43.2% | 43.2% | 41.7% | 46.5% | 44.6% | 43.8% | 45.8% | 46.5% | 42.2% | 43.5% | 38.4% |
| Operating income | $258.0M | $289.0M | $241.0M | $125.0M | $425.0M | $243.0M | $236.0M | $294.0M | $317.0M | $218.0M | $326.0M | $62.0M |
| Net income | $163.0M | $187.0M | $157.0M | $80.0M | $332.0M | $186.0M | $193.0M | $99.0M | $216.0M | -$51.0M | $93.0M | $22.0M |
| Net margin | 8.4% | 11.2% | 9.4% | 5.6% | 16.7% | 11.2% | 11.4% | 5.6% | 11.4% | −2.8% | 4.7% | 1.6% |
| Diluted EPS | $1.34 | $1.54 | $1.29 | $0.65 | $2.68 | $1.50 | $1.54 | $0.80 | $1.72 | $-0.41 | $0.75 | $0.17 |
| EBITDA | $336.0M | $347.0M | $296.0M | $181.0M | $482.0M | $298.0M | $289.0M | $348.0M | $317.0M | $276.0M | $383.0M | $123.0M |
| Operating cash flow | $330.0M | -$122.0M | $311.0M | $93.0M | $294.0M | $286.0M | $180.0M | $221.0M | $340.0M | $182.0M | $153.0M | $20.0M |
| Free cash flow | $244.0M | -$165.0M | $269.0M | $57.0M | $219.0M | $233.0M | $127.0M | $182.0M | $259.0M | $127.0M | $101.0M | -$4.0M |
| Diluted shares | 121.8M | 121.8M | 121.9M | 123.0M | 123.7M | 124.1M | 124.7M | 124.7M | 125.7M | 124.2M | 124.6M | 124.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $143.0M | $1.19B | $227.0M | $166.0M | $167.0M | $226.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $5.07B | $4.08B | $2.79B | $2.70B | $2.49B | $2.54B |
| Total assets | $7.79B | $6.44B | $5.61B | $5.53B | $5.56B | $5.51B |
| Total liabilities | $7.54B | $6.34B | $5.58B | $5.39B | $5.08B | $5.32B |
| Shareholders' equity | $252.0M | $92.0M | $35.0M | $138.0M | $482.0M | $190.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology